Digital Ether Computing
Digital Ether Computing LLC (DEC LLC) is an AI drug company focused on revolutionizing drug discovery and development through advanced AI technologies. Their proprietary platforms, Liquid AI and Adaptive Human Learning AI, accelerate R&D for precision medicine drug discovery, design, and optimization, as well as Protein and RNA studies. They create novel compound libraries for challenging druggable targets, enhance ADMET properties to de-risk preclinical assets, and offer computational tools for protein informatics and functional genomics. Their D3OP platform integrates AI-driven insights, computational precision, and molecular innovation to transform the drug development pipeline from discovery to clinical readiness. DEC LLC offers flexible R&D partnerships and IP models, aiming to reduce drug development timelines from years to months and accelerate the path to clinical trials.
Digital Ether Computing
Digital Ether Computing LLC (DEC LLC) is an AI drug company focused on revolutionizing drug discovery and development through advanced AI technologies. Their proprietary platforms, Liquid AI and Adaptive Human Learning AI, accelerate R&D for precision medicine drug discovery, design, and optimization, as well as Protein and RNA studies. They create novel compound libraries for challenging druggable targets, enhance ADMET properties to de-risk preclinical assets, and offer computational tools for protein informatics and functional genomics. Their D3OP platform integrates AI-driven insights, computational precision, and molecular innovation to transform the drug development pipeline from discovery to clinical readiness. DEC LLC offers flexible R&D partnerships and IP models, aiming to reduce drug development timelines from years to months and accelerate the path to clinical trials.